Skip to Main Content
Newsroom
BD & Partnering
Get in Touch
LinkedIn
X Mobile
Editas Medicine Linkedin
Research and Pipeline
CRISPR Gene Editing
For Patients
Who We Are
Join Our Team
Investors
Newsroom
BD & Partnering
Get in Touch
LinkedIn
X Mobile
Purchasing Policy Terms and Conditions
+
-
Editas Newsroom
Aug
5
Editas Medicine Announces Second Quarter 2026 Results and Business Updates
Aug
4
Editas Medicine Strengthens Board of Directors with Appointment of Patrick T. Ellinor, M.D., Ph.D.
May
28
Editas Medicine Announces Updated Presentation Time for Upcoming Investor Conference